Co-Diovan

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Hydrochlorothiazide 25mg (micronized);  ; Valsartan 320mg;  ;  ;  

Disponibbli minn:

Novartis New Zealand Ltd

INN (Isem Internazzjonali):

Hydrochlorothiazide 25 mg (micronized)

Dożaġġ:

320mg/25mg

Għamla farmaċewtika:

Film coated tablet

Kompożizzjoni:

Active: Hydrochlorothiazide 25mg (micronized)   Valsartan 320mg       Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Iron oxide yellow Macrogol 4000 Magnesium stearate Microcrystalline cellulose Purified talc Titanium dioxide

Unitajiet fil-pakkett:

Blister pack, PVC/PVDC/Alu foil, 28 tablets

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Novartis Pharma Schweizerhalle AG

Indikazzjonijiet terapewtiċi:

Co-Diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. These fixed dose combinations should be used as second line.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, PA/Al/PVC foil - 28 tablets - 36 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PVC/PVDC/Alu foil - 28 tablets - 36 months from date of manufacture stored at or below 25°C

Data ta 'l-awtorizzazzjoni:

2006-03-03